PURCHASE ORDER
Active75N98026P00626
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH OLAO
$206.9K
obligated · signed 4 months ago
PROJECT DESCRIPTION: THE PROJECT INVOLVES PERFORMING GENOME SEQUENCING OF DNA SAMPLES OBTAINED FROM PATIENTS DIAGNOSED WITH LEWY BODY DEMENTIA, AMYOTROPHIC LATERAL SCLEROSIS, ATYPICAL PARKINSONISM, OR FRONTOTEMPORAL DEMENTIA. THIS WILL BE DONE USING
Performance timeline
Start
May 29, 2026
End
May 28, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: May 28, 2027
OLINK PROTEOMICS INC
Contract 75N98026P00626
UEI
LY8PXLZYEXL7
Parent Company
OLINK PROTEOMICS INC
Capabilities & Certifications
Headquarters Location
Congressional District: 05
Current Obligation
$206,861
Base + Exercised Options
$206,861
Total Ceiling Value
$206,861
Contract Type
FIRM FIXED PRICE
NAICS
BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 05
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH OLAO
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NINDS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.